Table 7.6b

Immunosuppression Used for Maintenance Prior to Discharge, 1994 to 2003

Recipients with Pancreas After Kidney (PAK) Transplants

		Year of Transplant
		1994	1995	1996	1997	1998	1999	2000	2001	2002	2003
Functioning Graft at Discharge		45	60	97	114	140	207	276	289	338	316
With Immunosuppression Info		45	60	93	113	137	204	275	288	337	311
Corticosteroids	Category Usage	24.4%	21.7%	86.0%	94.7%	98.5%	89.7%	95.6%	92.7%	89.3%	81.0%
	Steroids	24.4%	21.7%	86.0%	94.7%	98.5%	89.7%	95.6%	92.7%	89.3%	81.0%
Cyclosporine	Category Usage	75.6%	36.7%	32.3%	20.4%	25.5%	14.2%	13.8%	9.7%	11.3%	8.4%
	Cyclosporin	75.6%	35.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Sandimmmune	2.2%	0.0%	10.8%	3.5%	3.6%	2.5%	2.2%	0.7%	0.6%	0.3%
	Neoral	0.0%	1.7%	21.5%	16.8%	21.9%	11.3%	12.0%	8.0%	8.9%	6.1%
	Gengraf	0.0%	0.0%	0.0%	0.0%	0.0%	0.5%	0.0%	1.0%	1.8%	1.9%
Tacrolimus	Category Usage	22.2%	53.3%	49.5%	78.8%	75.2%	83.3%	85.1%	90.6%	86.4%	80.7%
	FK506	22.2%	53.3%	49.5%	78.8%	75.2%	83.3%	85.1%	90.6%	86.4%	80.7%
Antimetabolites	Category Usage	91.1%	88.3%	90.3%	92.9%	90.5%	84.8%	82.2%	75.0%	73.9%	85.5%
	Azathioprine	91.1%	76.7%	10.8%	1.8%	4.4%	3.4%	1.8%	1.4%	0.3%	0.6%
	Mycophenolate mofetil	0.0%	13.3%	80.6%	92.0%	87.6%	82.4%	80.4%	73.6%	73.6%	84.9%
Other	Category Usage	0.0%	0.0%	0.0%	0.0%	0.7%	1.5%	8.4%	21.9%	19.3%	14.8%
	Rapamycin	0.0%	0.0%	0.0%	0.0%	0.7%	1.5%	8.4%	21.9%	19.3%	14.8%

Source: OPTN/SRTR Data as of May 3, 2004.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.